New report blames administration mismanagement, Gilead monopoly for shortages of COVID-19 drug

A new report says some hospitals around the country did not get enough of a critical drug used for COVID-19 patients. The FDA approved the drug, Remdesivir, for emergency use in May. But the report says after looking at the data, the Trump administration mismanaged its distribution. Anna Werner reports.